2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Roy L et al. | Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man. | 1985 | Circulation | pmid:3882264 |
Fitzgerald DJ et al. | The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans. | 1984 | Circulation | pmid:6428771 |
Wennmalm A et al. | Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication. | 1988 | Clin Physiol | pmid:3402185 |
Wennmalm A | Formation of prostacyclin during administration of beta 1-selective and non-selective beta-adrenergic antagonists in healthy humans. | 1992 | Clin Physiol | pmid:1347260 |
Wennmalm A et al. | Maintained hyperexcretion of thromboxane A2 metabolite in healthy young cigarette smokers: results from a prospective study in randomly sampled males with stable smoking habits. | 1993 | Clin Physiol | pmid:8519161 |
Cibattoni G et al. | Effects of sulindac on renal and extrarenal eicosanoid synthesis. | 1987 | Clin. Pharmacol. Ther. | pmid:3549118 |
Skarke C et al. | Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. | 2012 | Clin. Pharmacol. Ther. | pmid:22278334 |
Wennmalm A et al. | Non-invasive assessment of the cardiovascular eicosanoids, thromboxane A2 and prostacyclin, in randomly sampled males, with special reference to the influence of inheritance and environmental factors. | 1990 | Clin. Sci. | pmid:2176952 |
Watson ML et al. | Urinary kallikrein and systemic prostacyclin synthesis during sodium chloride infusion in normal man. | 1985 | Clin. Sci. | pmid:3884237 |
Wennmalm A et al. | 2,3-Dinor metabolites of thromboxane A2 and prostacyclin in urine from healthy human subjects: diurnal variation and relation to 24h excretion. | 1992 | Clin. Sci. | pmid:1330409 |
RÃ¥ngemark C and Wennmalm A | Cigarette smoking and urinary excretion of markers for platelet/vessel wall interaction in healthy women. | 1991 | Clin. Sci. | pmid:1649717 |
Förstermann U and Feuerstein TJ | Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine. | 1987 | Clin. Sci. | pmid:3308287 |
Watson ML et al. | Prostaglandins and kallikrein during volume expansion in normal man. | 1984 | Contrib Nephrol | pmid:6570094 |
Rautanen M et al. | Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs. | 1997 | Crit. Care Med. | pmid:9233750 |
Koivisto VA et al. | Stimulation of prostacyclin synthesis by physical exercise in type I diabetes. | 1989 | Diabetes Care | pmid:2507264 |
Closa D et al. | Changes of systemic prostacyclin and thromboxane A2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats. | 1993 | Dig. Dis. Sci. | pmid:7678383 |
Ross S et al. | Association of cyclooxygenase-2 genetic variant with cardiovascular disease. | 2014 | Eur. Heart J. | pmid:24796340 |
Lahoz C et al. | Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. | 1997 | Eur. J. Clin. Invest. | pmid:9352251 |
Vesterqvist O | Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS. | 1986 | Eur. J. Clin. Pharmacol. | pmid:3519239 |
Larsson PT et al. | Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation. | 1992 | Eur. J. Clin. Pharmacol. | pmid:1387607 |